Biodesix, Inc. (BDSX) - Cash Funds Calculated per Share

Corporate emblem and logo of Biodesix, Inc. (BDSX)

The integration of advanced data scientists into oncology diagnostics determines the cash per share dynamics, where the value of 2.58 serves as the current metric. Attracting experts through prestigious publications and comprehensive benefit packages supports innovation, yet the success of Biodesix, Inc. (BDSX) relies on the efficiency of its R&D pipeline and strict cost control until stable revenue is achieved.

BDSX Biodesix Corporation: Cash per Share in the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Biodesix, Inc.

- cash position and cash flow details:
Summary company analysis:Biodesix, Inc.
Original product of Biodesix

Effective scaling of Biodesix, Inc. (BDSX) diagnostic tests requires strict liquidity control to minimize operating losses. This metric is calculated by dividing the total amount of available cash by the number of shares outstanding. The current value of 2.58 determines the size of the financial reserve available to support each equity share. This indicator allows for an assessment of the business's resilience to inflation and the risk of inefficient capital utilization. The trend of cash per share over the period clearly captures the company's actual margin of safety.